| Companies sponsors |
Sanofi |
| Others |
Department of Health and Social Care |
| |
NHS England |
| |
Welsh Government |
| Patient carer groups |
Blood Cancer UK |
| |
Myeloma UK |
| Professional groups |
Association of Cancer Physicians |
| |
Cancer Research UK |
| |
Royal College of Physicians |
| |
Royal College of Radiologists |
| |
UK Myeloma Society |
| Associated public health groups |
None |
| Comparator companies |
Advanz Pharma (dexamethasone, lenalidomide) confidentiality agreement not signed, not participating |
| |
Aspen (dexamethasone) confidentiality agreement not signed, not participating |
| |
Aspire Pharma (dexamethasone) confidentiality agreement not signed, not participating |
| |
Bristol Myers Squibb (lenalidomide, pomalidomide) confidentiality agreement not signed, not participating |
| |
Cipla (lenalidomide) confidentiality agreement not signed, not participating |
| |
GlaxoSmithKline (belantamab mafodotin) confidentiality agreement not signed, not participating |
| |
Glenmark Pharmaceuticals (dexamethasone) confidentiality agreement not signed, not participating |
| |
hameln pharma (dexamethasone) confidentiality agreement not signed, not participating |
| |
Hospira (dexamethasone) confidentiality agreement not signed, not participating |
| |
Janssen-Cilag (ciltacabtagene autoleucel, daratumumab) confidentiality agreement not signed, not participating |
| |
Laboratoires CTRS (dexamethasone) – confidentiality agreement not signed, not participating |
| |
Martindale Pharma (dexamethasone) – confidentiality agreement not signed, not participating |
| |
Mylan (lenalidomide) – confidentiality agreement not signed, not participating |
| |
Noridem Enterprises (dexamethasone) – confidentiality agreement not signed, not participating |
| |
Panpharma (dexamethasone) – confidentiality agreement not signed, not participating |
| |
Pfizer (elranatamab) – confidentiality agreement not signed, not participating |
| |
Piramal Critical Care (lenalidomide) – confidentiality agreement not signed, not participating |
| |
Ranbaxy (lenalidomide) – confidentiality agreement not signed, not participating |
| |
Rosemont Pharmaceuticals (dexamethasone) – confidentiality agreement not signed, not participating |
| |
Sandoz (lenalidomide) – confidentiality agreement not signed, not participating |
| |
Synchrony Pharma (dexamethasone) – confidentiality agreement not signed, not participating |
| |
Takeda (ixazomib) – confidentiality agreement not signed, not participating |
| |
Teva (lenalidomide) – confidentiality agreement not signed, not participating |
| |
Thame Laboratories (dexamethasone) – confidentiality agreement not signed, not participating |
| |
Thornton & Ross (lenalidomide) – confidentiality agreement not signed, not participating |
| |
Wockhardt (dexamethasone) – confidentiality agreement not signed, not participating |
| |
Zentiva (lenalidomide) – confidentiality agreement not signed, not participating |
| General commentators |
All Wales Therapeutics and Toxicology Centre |
| |
British National Formulary |
| |
Department of Health - Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Health Technology Wales (HTW) |
| |
Medicines and Healthcare products Regulatory Agency |
| |
Scottish Medicines Consortium |
| |
Welsh Health Specialised Services Committee |
| Relevant research groups |
Institute of Cancer Research |
| |
National Institute for Health Research |